Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000795551-03-000023
Filing Date
2003-08-14
Accepted
2003-08-14 15:28:35
Documents
7
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 Q2 2003 10-Q a10q203.htm 10-Q 251663
3 EXHIBIT 10.1 cj08.htm EX-99.A4 7854
4 EXHIBIT 10.2 bs08.htm EX-99.A4 9619
5 EXHIBIT 10.3 wcf03.htm EX-99.2K 7795
6 EXHIBIT 31.1 AND 31.2 cert31_x.htm EX-31 21453
7 EXHIBIT 32.1 cert32_1.htm EX-32 2482
8 EXHIBIT 32.2 cert32_2.htm EX-32 3074
  Complete submission text file 0000795551-03-000023.txt   306177
Mailing Address 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518
Business Address 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518 7702710233
THERAGENICS CORP (Filer) CIK: 0000795551 (see all company filings)

EIN.: 581528626 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14339 | Film No.: 03847170
SIC: 2834 Pharmaceutical Preparations